Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
132.50
-1.50 (-1.12%)
May 8, 2026, 1:30 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 11.23 billion as of May 8, 2026. Its market cap has decreased by -24.29% in one year.
Market Cap
11.23B
Enterprise Value
10.32B
Revenue
4.20B
Ranking
n/a
PE Ratio
10.81
Stock Price
132.50
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 11.23B, an increase of 1,016.55%. That is a compound annual growth rate of 14.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 11.23B | -9.25% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 244.59B |
| Caliway Biopharmaceuticals | 157.19B |
| Lotus Pharmaceutical | 61.23B |
| Heron Neutron Medical | 56.94B |
| Ever Supreme Bio Technology | 12.13B |
| Excelsior Medical | 12.11B |
| Locus Cell | 12.00B |
| Handa Pharmaceuticals | 11.70B |